Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1988 Jan;81(1):47–51. doi: 10.1172/JCI113308

Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity.

R B Diasio 1, T L Beavers 1, J T Carpenter 1
PMCID: PMC442471  PMID: 3335642

Abstract

Severe neurotoxicity due to 5-fluorouracil (FUra) has previously been described in a patient with familial pyrimidinemia. We now report the biochemical basis for both the pyrimidinemia and neurotoxicity in a patient we have recently studied. After administration of a "test" dose of FUra (25 mg/m2, 600 microCi[6-3H]FUra by intravenous bolus) to a patient who had previously developed neurotoxicity after FUra, a markedly prolonged elimination half-life (159 min) was observed with no evidence of FUra catabolites in plasma or cerebrospinal fluid and with 89.7% of the administered dose being excreted into the urine as unchanged FUra. Using a sensitive assay for dihydropyrimidine dehydrogenase in peripheral blood mononuclear cells, we demonstrated complete deficiency of enzyme activity in the patient and partial deficiency of enzyme activity in her father and children consistent with an autosomal recessive pattern of inheritance. Patients who are deficient in this enzyme are likely to develop severe toxicity after FUra administration.

Full text

PDF
49

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bakkeren J. A., De Abreu R. A., Sengers R. C., Gabreëls F. J., Maas J. M., Renier W. O. Elevated urine, blood and cerebrospinal fluid levels of uracil and thymine in a child with dihydrothymine dehydrogenase deficiency. Clin Chim Acta. 1984 Jul 31;140(3):247–256. doi: 10.1016/0009-8981(84)90206-7. [DOI] [PubMed] [Google Scholar]
  2. Berger R., Stoker-de Vries S. A., Wadman S. K., Duran M., Beemer F. A., de Bree P. K., Weits-Binnerts J. J., Penders T. J., van der Woude J. K. Dihydropyrimidine dehydrogenase deficiency leading to thymine-uraciluria. An inborn error of pyrimidine metabolism. Clin Chim Acta. 1984 Aug 31;141(2-3):227–234. doi: 10.1016/0009-8981(84)90014-7. [DOI] [PubMed] [Google Scholar]
  3. Heggie G. D., Sommadossi J. P., Cross D. S., Huster W. J., Diasio R. B. Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile. Cancer Res. 1987 Apr 15;47(8):2203–2206. [PubMed] [Google Scholar]
  4. Koenig H., Patel A. Biochemical basis for fluorouracil neurotoxicity. The role of Krebs cycle inhibition by fluoroacetate. Arch Neurol. 1970 Aug;23(2):155–160. doi: 10.1001/archneur.1970.00480260061008. [DOI] [PubMed] [Google Scholar]
  5. Koenig H., Patel A. Biochemical basis of the acute cerebellar syndrome in 5-fluorouracil chemotherapy. Trans Am Neurol Assoc. 1969;94:290–292. [PubMed] [Google Scholar]
  6. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  7. Lynch H. T., Droszcz C. P., Albano W. A., Lynch J. F. "Organic brain syndrome" secondary to 5-fluorouracil toxicity. Dis Colon Rectum. 1981 Mar-Apr;24(2):130–131. doi: 10.1007/BF02604302. [DOI] [PubMed] [Google Scholar]
  8. MARSH J. C., PERRY S. THE REDUCTION OF THYMINE BY HUMAN LEUKOCYTES. Arch Biochem Biophys. 1964 Jan;104:146–149. doi: 10.1016/s0003-9861(64)80046-1. [DOI] [PubMed] [Google Scholar]
  9. MOERTEL C. G., REITEMEIER R. J., BOLTON C. F., SHORTER R. G. CEREBELLAR ATAXIA ASSOCIATED WITH FLUORINATED PYRIMIDINE THERAPY. Cancer Chemother Rep. 1964 Sep;41:15–18. [PubMed] [Google Scholar]
  10. Sommadossi J. P., Gewirtz D. A., Diasio R. B., Aubert C., Cano J. P., Goldman I. D. Rapid catabolism of 5-fluorouracil in freshly isolated rat hepatocytes as analyzed by high performance liquid chromatography. J Biol Chem. 1982 Jul 25;257(14):8171–8176. [PubMed] [Google Scholar]
  11. Tuchman M., Stoeckeler J. S., Kiang D. T., O'Dea R. F., Ramnaraine M. L., Mirkin B. L. Familial pyrimidinemia and pyrimidinuria associated with severe fluorouracil toxicity. N Engl J Med. 1985 Jul 25;313(4):245–249. doi: 10.1056/NEJM198507253130407. [DOI] [PubMed] [Google Scholar]
  12. Wadman S. K., Beemer F. A., de Bree P. K., Duran M., van Gennip A. H., Ketting D., van Sprang F. J. New defects of pyrimidine metabolism. Adv Exp Med Biol. 1984;165(Pt A):109–114. doi: 10.1007/978-1-4684-4553-4_19. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES